Biofilm formation by Escherichia coli isolated from patients with urinary tract infections

Clinical Nephrology

Volumn 71, Issue 5, 2009, Pages 501-507

  Salo, Jarmo ^a   Sevander, J J ^a   Tapiainen, T ^a   Ikaheimo I ^a   Pokka, T ^a   Koskela, M ^a   Uhari, M ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Biofilms; Drug resistance; Escherichia coli; Microbial; Urinary tract infections

Indexed keywords

CEFALEXIN; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; MECILLINAM; NITROFURANTOIN; POLYSTYRENE; TRIMETHOPRIM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; BIOFILM; CHILD; CONFOCAL LASER MICROSCOPY; CYSTITIS; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROTITER PLATE ASSAY; NONHUMAN; OPTICAL DENSITY; PRESCHOOL CHILD; PYELONEPHRITIS; SCANNING ELECTRON MICROSCOPY; URINARY TRACT INFECTION; UROSEPSIS; ADOLESCENT; BACTERIAL COUNT; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; ESCHERICHIA COLI INFECTION; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE; URINE; UROTHELIUM;

ADOLESCENT; ADULT; BIOFILMS; CHILD; CHILD, PRESCHOOL; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; URINARY TRACT INFECTIONS; URINE; UROTHELIUM; YOUNG ADULT;

EID: 67649397641     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71501     Document Type: Article

References (34)

1. Adams JL, McLean RJ. Impact of rpoS deletion on Escherichia coli biofilms. Appl Environ Microbiol. 1999; 65: 4285-4287.
2. American Academy of P. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Pediatrics. 1999; 103: 843-852.
3. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003; 301: 105-107.
4. Armitage P BG, Matthews JNS. Statistical methods in medical research. 4th ed. Oxford: Blackwell Science; 2002.
5. Banning N, Toze S, Mee BJ. Persistence of biofilm-associated Escherichia coli and Pseudomonas aeruginosa in groundwater and treated effluent in a laboratory model system. Microbiology. 2003; 149:47-55.
6. Branda SS, Vik S, Friedman L, Kolter R. Biofilms: the matrix revisited. Trends Microbiol. 2005; 13:20-26.
7. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284: 1318-1322.
8. Danese PN, Pratt LA, Dove SL, Kolter R. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol. 2000a; 37: 424-432.
9. Danese PN, Pratt LA, Kolter R. Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J Bacteriol. 2000b; 182: 3593-3596.
10. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15: 167-193.
11. Finer G, Landau D. Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis. 2004; 4: 631-635.
12. FiRe. Antimicrobial resistance statistics 1988 - 2005. 2008 [updated 2008; cited]; Available from: http://www.ktl.fi/portal/english/ projects/fire/finres/finres_antimicrobial_resistance_statistics/.
13. Fux CA, Shirtliff M, Stoodley P, Costerton JW. Can laboratory reference strains mirror "real-world" pathogenesis? Trends Microbiol. 2005; 13: 58-63.
14. Hancock V, Ferrieres L, Klemm P. Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains. FEMS Microbiol Lett. 2007; 267: 30-37.
15. Hoffman LR, D'Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature. 2005; 436: 1171-1175.
16. Hooton TM. Pathogenesis of urinary tract infections: an update. J Antimicrob Chemother. 2000; 46 (Suppl 1): 1-7.
17. Jacobson SH, Hansson S, Jakobsson B. Vesico-ureteric reflux: occurrence and long-term risks. Acta Paediatr. 1999; 88 (Suppl): 22-30.
18. Jodal U, Lindberg U, Lincoln K. Level diagnosis of symptomatic urinary tract infections in childhood. Acta Paediatr Scand. 1975; 64: 201-208.
19. Kanamaru S, Kurazono H, Terai A, Monden K, Kumon H, Mizunoe Y, et al. Increased biofilm formation in Escherichia coli isolated from acute prostatitis. Int J Antimicrob Agents. 2006; 28 (Suppl 1): S21-S25.
20. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001; 322: 1571.
21. Lynch SV, Dixon L, Benoit MR, Brodie EL, Keyhan M, Hu P, et al. Role of the rapA Gene in Controlling Antibiotic Resistance of Escherichia coli Biofilms. Antimicrob Agents Chemother. 2007; 51: 3650-3658.
22. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001; 69: 4572-4579.
23. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005; 40: 643-54.
24. Pratt LA, Kolter R. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol. 1998; 30: 285-293.
25. Rediske AM, Roeder BL, Brown MK, Nelson JL, Robison RL, Draper DO et al. Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model. Antimicrob Agents Chemother. 1999; 43: 1211-1214.
26. Reid G, Kang YS, Lacerte M, Tieszer C, Hayes KC. Bacterial biofilm formation on the bladder epithelium of spinal cord injured patients. II. Toxic outcome on cell viability. Paraplegia. 1993; 31: 494-499.
27. Reisner A, Krogfelt KA, Klein BM, Zechner EL, Molin S. In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors. J Bacteriol. 2006; 188: 3572-3581.
28. Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 2007; 4: e329.
29. Smith AW. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev. 2005; 57: 1539-1550.
30. Soto SM, Smithson A, Horcajada JP, Martinez JA, Mensa JP, Vila J. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect. 2006; 12: 1034-1036.
31. Soto SM, Smithson A, Martinez JA, Horcajada JP, Mensa J, Vila J. Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol. 2007; 177: 365-368.
32. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001; 358: 135-138.
33. Tenke P, Kovacs B, Jackel M, Nagy E. The role of biofilm infection in urology. World J Urol. 2006; 24: 13-20.
34. Wakimoto N, Nishi J, Sheikh J, Nataro JP, Sarantuya J, Iwashita M, et al. Quantitative biofilm assay using a microtiter plate to screen for enteroaggregative Escherichia coli. Am J Trop Med Hyg. 2004; 71: 687-690.